Lung Cancer
Volume 45 , Pages S3-S9 , August 2004

Tobacco smoking and cancer: a brief review of recent epidemiological evidence

  • A.J. Sasco

      Affiliations

    • International Agency for Research on Cancer, 150 Cours Albert Thomas, 69008 Lyon, France
    • lnstitut National de la Santé et de la Recherche Médicale, 150 Cours Albert Thomas, 69008 Lyon, France
  • ,
  • M.B. Secretan

      Affiliations

    • International Agency for Research on Cancer, 150 Cours Albert Thomas, 69008 Lyon, France
  • ,
  • K. Straif

      Affiliations

    • International Agency for Research on Cancer, 150 Cours Albert Thomas, 69008 Lyon, France
    • Corresponding Author InformationCorrespondence to: K. Straif, IARC/CIE, 150 Cours Albert Thomas, 69372 Lyon Cedex 8, France Tel.: +33-(0)-4-72-73-85-11; fax: +33-(0)-4-72-73-83-19.

References 

  1. Doll R, Hill AB. Smoking and carcinoma of the Lung. Preliminary report. Br Med J. 1950;2:739
  2. Wynder EL, Graham EA. Tobacco smoking as a possible etiologic factor in bronchogenic carcinoma. J Am Med Assoc. 1950;143:329–336
  3. Doll R. The first reports on smoking and Lung cancer. Clio Med. 1998;46:130–142
  4. IARC . In: IARC Monographs on the evaluation of the carcinogenic risk of chemicals to humans, Vol. 38, Tobacco Smoking. Lyon, France: IARC; 1986;
  5. IARC . In: IARC Monographs on the evaluation of the carcinogenic risk of chemicals to humans, Vol. 83, Tobacco Smoke and Involuntary Smoking. Lyon, France: IARC Press; 2004;
  6. IARC . In: IARC Monographs on the evaluation of the carcinogenic risk of chemicals to humans, Vol. 70, Epstein-Barr Virus and Kaposi's Sarcoma, Herpesvirus/human Herpesvirus 8. Lyon, France: IARC; 1999;
  7. IARC . In: IARC Monographs on the evaluation of the carcinogenic risk of chemicals to humans, Vol. 44, Alcohol Drinking. Lyon, France: IARC; 1988;
  8. IARC . In: IARC Monographs on the evaluation of the carcinogenic risk of chemicals to humans, Vol. 37, Tobacco Habits other than Smoking; betel-quid and areca-nut chewing; and some related nitrosamines. Lyon, France: IARC; 1985;
  9. IARC . In: IARC Monographs on the evaluation of the carcinogenic risk of chemicals to humans, Vol. 61, Schistosomes, Liver Flukes and Helicobacter pylori. Lyon, France: IARC; 1994;
  10. IARC . In: IARC Monographs on the evaluation of the carcinogenic risk of chemicals to humans, Vol. 59, Hepatitis Viruses. Lyon, France: IARC; 1994;
  11. IARC . In: IARC Handbook of cancer prevention, Vol. 6, Weight Control and Physical Activity. Lyon, France: IARC Press; 2002;
  12. IARC . In: IARC Monographs on the evaluation of the carcinogenic risk of chemicals to humans, Vol. 64, Human Papillomaviruses. Lyon, France: IARC; 1995;
  13. IARC . In: IARC Monographs on the evaluation of the carcinogenic risk of chemicals to humans, Suppl.7, Overall Evaluations of Carcinogenicity: An updating of IARC Monographs Volumes 1 to 42. Lyon, France: IARC; 1987;
  14. IARC . In: IARC Handbook of cancer prevention, Vol. 8, Fruit and Vegetables. Lyon, France: IARC Press; 2003;
  15. Stewart BW, Kleihues P. In: World Cancer Report. Lyon, France: IARC Press; 2003;
  16. Boyle P, Autier P, Bartelink H, Baselga J, Boffetta P, Burn J, et al. European Code Against Cancer and scientific justification: third version (2003). Ann Oncol. 2003;14:973–1005
  17. Korte JE, Hertz-Picciotto I, Schulz MR, Ball LM, Duell EJ. The contribution of benzene to smoking-induced Leukemia. Environ Health Perspect. 2000;108:333–339
  18. Brennan P, Bogillot 0, Greiser E, Chang-Claude J, Wahrendorf J, Cordier S, et al. The contribution of cigarette smoking to bladder cancer in women (pooled European data). Cancer Causes Control. 2001;12:411–417
  19. Brennan P, Bogillot 0, Cordier S, Greiser E, SchiLL W, Vineis P, et al. Cigarette smoking and bladder cancer in men: a pooled analysis of 11 casecontrol studies. Int J Cancer. 2000;86:289–294
  20. Peto R, Lopez AD, Boreham J, Thun M, Heath C. Mortality from smoking in developed countries 1950–2000: Indirect estimates from National Vital Statistics. Oxford: Oxford University Press; 1994;

PII: S0169-5002(04)80002-3

doi: 10.1016/j.lungcan.2004.07.998

Lung Cancer
Volume 45 , Pages S3-S9 , August 2004